NCT04964271Active, not recruiting
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Prostate Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)
Source: ClinicalTrials.gov · Last updated 2 Feb 2026
Brief summary (registry, in English)
This is an exploratory research study with the aim of identifying specific cancer biomarkers in various subtypes of prostate cancer. Blood samples will be collected from 60 participants divided into 40 patients and 20 healthy donors.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 7 Jul 2021
- Start date
- 9 Sept 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- Tethis S.p.A.
- Diseases
- Prostate cancer
- NCT number
- NCT04964271
What you commit to
- Study type: Observational
- Planned participants: 60
- From 9 Sept 2021 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of other malignancies other than prostate cancer (for healthy participants includes also prostate cancer)
- Undergone surgery or treatment for prostate cancer before enrolment
- Presence of known severe coagulation or haematological disorder
Other
- Absence of written signed informed consent for participation in the study
Who the study is looking for
- Participant is willing and able to give and sign a written informed consent for participation in the study
- Male, aged 18 years or above
- Diagnosed with prostate cancer at low or high risk
- Candidate to active surveillance (in case of low-risk disease) or treatment with curative intent such as radical prostatectomy or radiation therapy (in case of low risk patients not willing to undergo active surveillance or patients with high risk disease)
- Healthy participants undergoing a visit at the site for reason other than cancer diagnosis (including prostate cancer)
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ospedale San Raffaele Coordinator of this site? Confirm its status | Milan | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.